Tennador Sanderson

Tennador Sanderson, PhD has a strong background in clinical research and development. They have held various roles at different pharmaceutical companies, including Cara Therapeutics, Allergan, and Merck. Tennador's most recent role was as a Sr. Director of Clinical Research & Development at Cara Therapeutics starting in April 2020. Prior to that, they worked as an Associate Director of Clinical Development at Allergan from April 2017 to March 2020. They also held positions at Allergan as a Sr. Clinical Scientist from 2013 to 2017 and as a Clinical Scientist II from June 2011 to July 2013. Tennador started their career as a Clinical Pharmacology Scientist at Merck in October 2009, where they worked until June 2011.

Tennador Sanderson, PhD holds a Bachelor of Science degree from Thomas Jefferson University, a Master of Business Administration degree from Rosemont College, and a Doctor of Philosophy degree from Walden University.